NCT06625684 Key Longitudinal Associations With Risk and Glioblastoma Outcomes
| NCT ID | NCT06625684 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Glioblastoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-12-10 |
| Primary Completion | 2029-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-12-10 with a primary completion date of 2029-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to find out what factors affect the health and risks in adults with glioblastoma (GBM), a grade 4 brain cancer. The main questions it aims to answer are: * How do genetic and immune system factors impact survival and quality of life in GBM patients? * What occupational and medical history factors are linked to the risk of getting GBM? Participants will: * Fill out an online survey about their medical history and lifestyle. Participants will have the chance to give a blood sample (from the outer arm) for genetic and immune system testing. Blood samples will be given using a home collection kit provided by the study team.
Eligibility Criteria
Inclusion Criteria: * At least 18 years old * Pathologically-confirmed diagnosis of glioblastoma multiforme (GBM) or grade 4 brain tumor * Participant is accessible for follow-up (has a working email address) * Participant is willing and able to comply with the study requirements Exclusion Criteria: * Those who cannot read either English or Spanish * Those who cannot view an online survey
Contact & Investigator
Quinn Ostrom, PhD
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT06625684 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Glioblastoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06625684 currently recruiting?
Yes, NCT06625684 is actively recruiting participants. Contact the research team at GBMsurvey@duke.edu for enrollment information.
Where is the NCT06625684 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT06625684 clinical trial?
NCT06625684 is sponsored by Duke University. The principal investigator is Quinn Ostrom, PhD at Duke University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.